MM

Mohamed Mohamed Haroon

Active Director Director DIN 10588384
DIN 10588384 First appointment Apr 2024 Primary industry Professional Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Mohamed Mohamed Haroon

Data last updated:

Mohamed Mohamed Haroon is a Director at Sturnus Biotech Private Limited (since 2024). The company operates in Professional Services.

DIN 10588384
Primary Designation Director
Industry Professional Services
First Appointment 11 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sturnus Biotech Private Limited U72100KA2024PTC187364
Director11 Apr 20242024Active

Board colleagues of Mohamed Mohamed Haroon

NameDINCompanyDesignation
Praveen Kumar Vemula07936235Sturnus Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sturnus Biotech Private Limited
Premium access

Shareholding and investment profile for Mohamed Mohamed Haroon

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohamed Mohamed Haroon

Mohamed Mohamed Haroon currently holds 1 directorship: Sturnus Biotech Private Limited (Director, since 11 Apr 2024).

Mohamed Mohamed Haroon was first appointed on 11 Apr 2024 as Director at Sturnus Biotech Private Limited.

The current boards of Mohamed Mohamed Haroon's companies include Praveen Kumar Vemula (Sturnus Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available